Publications
Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV, Vuorinen A, Da Cunha T, Wolber G, Classen-Houben D, Doblhoff O, Schuster D, Odermatt A
The Journal of steroid biochemistry and molecular biology, 18 Jan 2011
Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.
Wendland T, Daubner B, Pichler WJ
British journal of clinical pharmacology, 12 Jan 2011
Nouveaux développements dans l’analyse de proteins intactes par CE-TOF/MS
Schappler J, Staub A, Rudaz S, Veuthey JL
Spectra Analyse, 2011, no. 281, p. 24-30 , 1 Jan 2011
Retrospective analysis of stimulant abuse cases reported to the Swiss Toxicological Information Centre during 1997-2009.
Bruggisser M, Ceschi A, Bodmer M, Wilks MF, Kupferschmidt H, Liechti ME
Swiss medical weekly, 29 Déc 2010
Synergistic effect of hyaluronate fragments in retinaldehyde-induced skin hyperplasia which is a Cd44-dependent phenomenon.
Barnes L, Tran C, Sorg O, Hotz R, Grand D, Carraux P, Didierjean L, Stamenkovic I, Saurat JH, Kaya G
PloS one, 24 Déc 2010
The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells.
Zahno A, Brecht K, Morand R, Maseneni S, Török M, Lindinger PW, Krähenbühl S
Biochemical pharmacology, 13 Nov 2010
Specific transgenerational imprinting effects of the endocrine disruptor methoxychlor on male gametes.
Stouder C, Paoloni-Giacobino A
Reproduction (Cambridge, England), 11 Nov 2010
Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.
Elsheikh A, Lavergne SN, Castrejon JL, Farrell J, Wang H, Sathish J, Pichler WJ, Park BK, Naisbitt DJ
Journal of immunology (Baltimore, Md. : 1950), 29 Oct 2010
Shotgun proteomics: a relative quantitative approach using Off-Gel electrophoresis and LC-MS/MS.
Geiser L, Dayon L, Vaezzadeh AR, Hochstrasser DF
Methods in molecular biology (Clifton, N.J.), 28 Oct 2010
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability.
Ancrenaz V, Daali Y, Fontana P, Besson M, Samer C, Dayer P, Desmeules J
Current drug metabolism, 15 Oct 2010